PubMed:22295085
Annnotations
DisGeNET
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T0 | 42-45 | gene:4771 | denotes | NF2 |
| T1 | 63-85 | disease:C0027859 | denotes | vestibular schwannomas |
| R1 | T0 | T1 | associated_with | NF2,vestibular schwannomas |
Allie
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| SS1_22295085_2_0 | 116-140 | expanded | denotes | neurofibromatosis type 2 |
| SS2_22295085_2_0 | 142-145 | abbr | denotes | NF2 |
| SS1_22295085_2_1 | 239-261 | expanded | denotes | vestibular schwannomas |
| SS2_22295085_2_1 | 263-265 | abbr | denotes | VS |
| SS1_22295085_5_0 | 627-649 | expanded | denotes | loss of heterozygosity |
| SS2_22295085_5_0 | 651-654 | abbr | denotes | LOH |
| AE1_22295085_2_0 | SS1_22295085_2_0 | SS2_22295085_2_0 | abbreviatedTo | neurofibromatosis type 2,NF2 |
| AE1_22295085_2_1 | SS1_22295085_2_1 | SS2_22295085_2_1 | abbreviatedTo | vestibular schwannomas,VS |
| AE1_22295085_5_0 | SS1_22295085_5_0 | SS2_22295085_5_0 | abbreviatedTo | loss of heterozygosity,LOH |
PubmedHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 116-133 | HP_0001067 | denotes | neurofibromatosis |
| T2 | 147-152 | HP_0002664 | denotes | tumor |
| T3 | 214-220 | HP_0002664 | denotes | tumors |
| T4 | 239-261 | HP_0009588 | denotes | vestibular schwannomas |
| T5 | 250-261 | HP_0100008 | denotes | schwannomas |
| T6 | 334-340 | HP_0002664 | denotes | tumors |
| T7 | 430-435 | HP_0002664 | denotes | tumor |
DisGeNET5_gene_disease
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 22295085-0#42#45#gene4771 | 461-481 | gene4771 | denotes | NCIPAL FINDINGS: NF2 |
| 22295085-0#63#85#diseaseC0027859 | 817-1264 | diseaseC0027859 | denotes | ve activity assessed using the Ki-67 labeling index were evaluated. We found 18 mutations in 16 cases of 30 schwannomas (53%). The mutations included eight frameshift mutations, seven nonsense mutations, one in-frame deletion, one splicing donor site, and one missense mutation. Nine patients (30%) showed allelic loss. No patient had aberrant hypermethylation of the NF2 gene and correlation between NF2 genetic alterations and tumor behavior was |
| 42#45#gene477163#85#diseaseC0027859 | 22295085-0#42#45#gene4771 | 22295085-0#63#85#diseaseC0027859 | associated_with | NCIPAL FINDINGS: NF2,"ve activity assessed using the Ki-67 labeling index were evaluated. We found 18 mutations in 16 cases of 30 schwannomas (53%). The mutations included eight frameshift mutations, seven nonsense mutations, one in-frame deletion, one splicing donor site, and one missense mutation. Nine patients (30%) showed allelic loss. No patient had aberrant hypermethylation of the NF2 gene and correlation between NF2 genetic alterations and tumor behavior was" |